Zdrowie i gospodarka · 09/09/2025
FDA Reopens Comment Period for M13B Bioequivalence Guidance
The FDA is extending the comment period for its draft guidance on bioequivalence for immediate-release solid oral dosage forms, allowing more time for public input.